Meyer Christopher G.B.'s Form 4 filing
Lesaka Technologies Inc (LSAK) · filed Nov 17, 2021
- Accession no.
- 0001062993-21-011054
- Filed
- Nov 17, 2021
- Trade date
- Nov 11-16, 2021
- Filing delay
- 6 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions. Open-market purchases total $587.4K. It was filed 6 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Meyer Christopher G.B.CIK 0001872089 | Director, Officer (Group Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 11, 2021 | Common Stock | AGrant or awardAcquired | +4,730 | $0.00 | $0 | 239,338 | Direct | |
| Nov 11, 2021 | Common Stock | AGrant or awardAcquired | +2,211 | $0.00 | $0 | 241,549 | Direct | |
| Nov 16, 2021 | Common Stock | PPurchaseAcquired | +104,520 | $5.62F2 | +$587,402.4 | 112,034 | Indirect | |
| Nov 16, 2021 | Common Stock | AGrant or awardAcquired | +202,229 | $0.00 | $0 | 283,371 | Direct | |
| Nov 16, 2021 | Common Stock | AGrant or awardAcquired | +34,671 | $0.00 | $0 | 422,562 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Purchase prices for the transactions reported here range from $5.54 to $5.74. Full information regarding the number of shares purchased at each separate price will be provided to the SEC, the issuer or its shareholders upon request.
Referenced by the price of 1 transaction in Table I.